INTS · Intensity Therapeutics, Inc. · Investor Relations
$3.50
+0.13 (+3.86%)
At close · Oct 1
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the cash and cash equivalents as of June 30, 2026, the Company's ability to continue its operations thereafter is dependent on obtaining additional capital, which is not within the Company's control. As a result, the Company believes there is substantial doubt about its ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$12.41M
Shares
3.26M
Volume · Oct 1
7392
Avg daily vol (3M)
30.74K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-12-31 00:00 UTC | 2026 Annual Meeting of Stockholders | Shareholder meeting |
| 2026-12-31 00:00 UTC | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-12-31 00:00 UTC | Second Quarter 2026 Financial Results Conference Call | Earnings call |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-11 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-08-11 | Second Quarter 2026 Financial Results Conference Call | Earnings call |